César Ugarte‐Gil

4.1k total citations · 1 hit paper
101 papers, 2.3k citations indexed

About

César Ugarte‐Gil is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, César Ugarte‐Gil has authored 101 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Infectious Diseases, 36 papers in Epidemiology and 18 papers in Surgery. Recurrent topics in César Ugarte‐Gil's work include Tuberculosis Research and Epidemiology (45 papers), Pneumocystis jirovecii pneumonia detection and treatment (12 papers) and Infectious Diseases and Tuberculosis (11 papers). César Ugarte‐Gil is often cited by papers focused on Tuberculosis Research and Epidemiology (45 papers), Pneumocystis jirovecii pneumonia detection and treatment (12 papers) and Infectious Diseases and Tuberculosis (11 papers). César Ugarte‐Gil collaborates with scholars based in Peru, United States and United Kingdom. César Ugarte‐Gil's co-authors include Paul Elkington, Jon S. Friedland, David Moore, Michael Drummond, Jennifer O. Lam, Trevor A. Crowell, Allison Lambert, Julie J. Paik, Fiona Pearson and Julia Critchley and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

César Ugarte‐Gil

89 papers receiving 2.2k citations

Hit Papers

Drug-resistant tuberculos... 2024 2026 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
César Ugarte‐Gil Peru 24 1.2k 849 551 237 224 101 2.3k
Theodore Lytras Greece 29 793 0.6× 1.1k 1.3× 505 0.9× 164 0.7× 298 1.3× 70 3.3k
Qinghong Guo China 15 1.8k 1.5× 317 0.4× 224 0.4× 311 1.3× 319 1.4× 55 3.4k
Sandro Vento Italy 31 738 0.6× 1.9k 2.2× 406 0.7× 166 0.7× 174 0.8× 127 3.6k
Paul Dolin United Kingdom 17 1.9k 1.6× 1.6k 1.9× 930 1.7× 146 0.6× 517 2.3× 37 3.4k
Sophia Koo United States 30 943 0.8× 1.4k 1.6× 499 0.9× 412 1.7× 168 0.8× 92 3.6k
Ian C. Michelow United States 22 793 0.6× 1.1k 1.3× 151 0.3× 267 1.1× 195 0.9× 59 2.5k
Nicolas Nagot France 31 1.3k 1.1× 2.2k 2.6× 420 0.8× 129 0.5× 262 1.2× 212 3.6k
Christopher Martin United States 21 395 0.3× 478 0.6× 346 0.6× 128 0.5× 257 1.1× 65 2.1k
Thomas D. Szucs Switzerland 41 414 0.3× 2.0k 2.4× 543 1.0× 402 1.7× 255 1.1× 263 5.6k
Toshio Naito Japan 27 497 0.4× 532 0.6× 221 0.4× 142 0.6× 304 1.4× 245 2.4k

Countries citing papers authored by César Ugarte‐Gil

Since Specialization
Citations

This map shows the geographic impact of César Ugarte‐Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by César Ugarte‐Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites César Ugarte‐Gil more than expected).

Fields of papers citing papers by César Ugarte‐Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by César Ugarte‐Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by César Ugarte‐Gil. The network helps show where César Ugarte‐Gil may publish in the future.

Co-authorship network of co-authors of César Ugarte‐Gil

This figure shows the co-authorship network connecting the top 25 collaborators of César Ugarte‐Gil. A scholar is included among the top collaborators of César Ugarte‐Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with César Ugarte‐Gil. César Ugarte‐Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Amy, Anthony Harries, Monica Galvan, et al.. (2025). Changes in incarceration and tuberculosis notifications from prisons during the COVID-19 pandemic in Europe and the Americas: a time-series analysis of national surveillance data. The Lancet Public Health. 10(4). e285–e294. 1 indexed citations
2.
Álvarez, Carlos, Evaldo Stanislau Affonso de Araújo, Elsa Baumeister, et al.. (2024). Differential Diagnosis in the Management of Acute Respiratory Infections through Point-of-Care Rapid Testing in a Post-Pandemic Scenario in Latin America: Special Focus on COVID-19, Influenza, and Respiratory Syncytial Virus. SHILAP Revista de lepidopterología. 4(2). 221–260. 3 indexed citations
3.
Martínez‐Pérez, Guillermo Z., César Ugarte‐Gil, Kingsley Akinroye, et al.. (2024). Point-of-care biochemistry for primary healthcare in low-middle income countries: a qualitative inquiry. BMC Primary Care. 25(1). 362–362.
4.
Sayyab, Shumaila, David Martínez-Enguita, Mika Gustafsson, et al.. (2024). A DNA Methylation Signature From Buccal Swabs to Identify Tuberculosis Infection. The Journal of Infectious Diseases. 231(1). e47–e58. 2 indexed citations
5.
Naidoo, Pren, César Ugarte‐Gil, Monde Muyoyeta, et al.. (2023). Improving measurement of tuberculosis care cascades to enhance people-centred care. The Lancet Infectious Diseases. 23(12). e547–e557. 10 indexed citations
6.
MacLean, Emily, Tatiana Cáceres, Giorgia Sulis, et al.. (2023). Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study. The Lancet Microbe. 4(6). e452–e460. 5 indexed citations
7.
Ruíz-Grosso, Paulo, Christian Loret de Mola, Larissa Otero, & César Ugarte‐Gil. (2023). Are trajectories of depressive symptoms during the first half of drug-sensitive pulmonary tuberculosis treatment associated with loss to follow-up? A secondary analysis of longitudinal data. BMJ Open. 13(7). e068235–e068235. 1 indexed citations
8.
Levano, Kelly S., David Tarazona, César Sánchez, et al.. (2022). NAT2 and CYP2E1 polymorphisms and antituberculosis drug‐induced hepatotoxicity in Peruvian patients. Molecular Genetics & Genomic Medicine. 10(8). e1987–e1987. 10 indexed citations
9.
Ugarte‐Gil, César, et al.. (2021). Characterization of the gut microbiota in diabetes mellitus II patients with adequate and inadequate metabolic control. BMC Research Notes. 14(1). 238–238. 5 indexed citations
10.
Ugarte‐Gil, César, et al.. (2021). Situación de la comorbilidad tuberculosis y diabetes en personas adultas en el Perú, 2016-2018. Revista Peruana de Medicina Experimental y Salud Pública. 38(2). 254–60. 9 indexed citations
11.
Carrillo‐Larco, Rodrigo M., Wilmer Cristobal Guzman‐Vilca, Fabiola Lèon‐Velarde, et al.. (2021). Peru – Progress in health and sciences in 200 years of independence. The Lancet Regional Health - Americas. 7. 100148–100148. 56 indexed citations
12.
Pollara, Gabriele, Carolin T. Turner, Joshua Rosenheim, et al.. (2021). Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease. Science Translational Medicine. 13(592). 31 indexed citations
13.
Lazo-Porras, María, Gabriela Prutsky, Patricia Barrionuevo, et al.. (2020). World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis. BMC Infectious Diseases. 20(1). 62–62. 23 indexed citations
14.
Gianella, Camila, M. Amalia Pesantes, César Ugarte‐Gil, David Moore, & Claudia Patricia Henao Lema. (2019). Vulnerable populations and the right to health: lessons from the Peruvian Amazon around tuberculosis control. International Journal for Equity in Health. 18(1). 28–28. 17 indexed citations
15.
Carrillo‐Larco, Rodrigo M., et al.. (2019). Is diabetes associated with malaria and malaria severity? A systematic review of observational studies. SHILAP Revista de lepidopterología. 4. 136–136. 12 indexed citations
16.
Carrillo‐Larco, Rodrigo M., et al.. (2019). Leptospirosis as a risk factor for chronic kidney disease: A systematic review of observational studies. PLoS neglected tropical diseases. 13(5). e0007458–e0007458. 19 indexed citations
17.
Heijden, Yuri F. van der, Fareed Abdullah, Bruno B. Andrade, et al.. (2018). Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting. Tuberculosis. 113. 153–162. 5 indexed citations
18.
Gianella, Camila, et al.. (2016). TB in Vulnerable Populations: The Case of an Indigenous Community in the Peruvian Amazon.. PubMed. 18(1). 55–68. 19 indexed citations
19.
Ugarte‐Gil, César, et al.. (2013). Conocimientos, actitudes y prácticas sobre la enfermedad de Carrión en población rural de Ancash, Perú. Revista Panamericana de Salud Pública. 33(5). 311–315. 2 indexed citations
20.
Várgas, Ciro Maguiña, et al.. (2006). Uso adecuado y racional de los antibióticos. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026